Skip to main content
Loading market data...

ONEQ holdings

Fidelity Nasdaq Composite Index ETF

Source: SEC Form N-PORT (opens in a new tab) Holdings as of Made public 24 Jul 2026

Positions

1,025 stored of 1,025 reported, largest first by weight

ONEQ holdings as of 31 May 2026, largest first
# Holding ISIN CUSIP Weight Value (USD) Type Issuer type Country Currency
1001 BRIDGFORD FOODS CORP US1087631032 108763103 <0.001% $23K Equity (common) Corporate United States USD
1002 BGM GROUP LTD BGM GROUP LTD CL A KYG7307E1237 Not reported <0.001% $20K Equity (common) Corporate Cayman Islands USD
1003 ABIOMED INC Not reported Not reported <0.001% $16K Equity (common) Corporate United States USD
1004 OPENDOOR TECHNOLOGIES INC OPENDOOR TECHNOLOGIES INC WT 11/20/2026 US6837121291 683712129 <0.001% $4K Equity (common) Corporate United States USD
1005 OPENDOOR TECHNOLOGIES INC OPENDOOR TECHNOLOGIES INC WT 11/20/2026 US6837121374 683712137 <0.001% $2K Equity (common) Corporate United States USD
1006 OPENDOOR TECHNOLOGIES INC OPENDOOR TECHNOLOGIES INC WT 11/20/2026 US6837121457 683712145 <0.001% $2K Equity (common) Corporate United States USD
1007 OMNIAB INC/OLD OMNIAB INC - 12.5 EARNOUT US68218J2024 68218J202 <0.001% $1K Equity (common) Corporate United States USD
1008 OMNIAB INC/OLD OMNIAB INC - 15.00 EARNOUT US68218J3014 68218J301 <0.001% $835 Equity (common) Corporate United States USD
1009 LIGAND PHARMACEUTICALS INC LIGAND PHARMA (TR BETA) CVR US53220K1732 53220K173 <0.001% $92 Equity (common) Corporate United States USD
1010 LIGAND PHARMACEUTICALS INC LIGAND PHARMA (GENERAL) CVR US53220K1997 53220K199 <0.001% $81 Equity (common) Corporate United States USD
1011 CARISMA THERAPEUTICS INC SESEN BIO INC CVR RT Not reported Not reported 0.000% $4 Equity (common) Corporate United States USD
1012 LIGAND PHARMACEUTICALS INC LIGAND PHARMA (GLUCAGON) CVR US53220K1815 53220K181 0.000% $3 Equity (common) Corporate United States USD
1013 SATSUMA PHARMACEUTICALS INC SATSUMA PHARMACEUTICALS INC CVR RT Not reported Not reported 0.000% $2 Equity (common) Corporate United States USD
1014 LIGAND PHARMACEUTICALS INC LIGAND PHARMACEUT(ROCHE) CVR US53220K2151 53220K215 0.000% $2 Equity (common) Corporate United States USD
1015 KINNATE BIOPHARMA INC KINNATE BIOPHARMA CVR RT Not reported Not reported 0.000% $1 Equity (common) Corporate United States USD
1016 AVADEL PHARMACEUTICALS PLC AVADEL PHARMACEUTICALS PLC CVR RT Not reported Not reported 0.000% $0 Equity (common) Corporate Ireland USD
1017 ASTRAZENECA PLC ASTRAZENECA PLC CVR RT Not reported Not reported 0.000% $0 Equity (common) Corporate United Kingdom USD
1018 OZON HOLDINGS PLC OZON HOLDINGS PLC ADR US69269L1044 69269L104 0.000% $0 Equity (common) Corporate Cyprus USD
1019 CLEMENTIA PHARMACEUTICALS INC CLEMENTIA PHARMACEUTICALS INC (CVR) Not reported Not reported 0.000% $0 Equity (common) Corporate Canada USD
1020 APPLIED GENETIC TECHNOLOGIES CORP APPLIED GENETIC TECHNOLOGIES CORP CVR Not reported Not reported 0.000% $0 Equity (common) Corporate United States USD
1021 CINCOR PHARMA INC CINCOR PHARMA INC CVR RT Not reported Not reported 0.000% $0 Equity (common) Corporate United States USD
1022 DOVA PHARMACEUTICALS INC DOVA PHARMACEUTICALS INC(CVR) RT Not reported Not reported 0.000% $0 Equity (common) Corporate United States USD
1023 MIRATI THERAPEUTICS INC MIRATI THERAPEUTICS INC CVR RT Not reported Not reported 0.000% $0 Equity (common) Corporate United States USD
1024 SANOFI SANOFI CVR RT Not reported Not reported 0.000% $0 Equity (common) Corporate France USD
1025 ROCHE HOLDING AG ROCHE HOLDING AG CVR Not reported Not reported 0.000% $0 Equity (common) Corporate Switzerland USD
IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme